查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571685

北美家庭醫療保健市場規模、佔有率、趨勢分析報告：按組成部分、按適應症、按地區、細分市場預測，2024-2030 年

North America Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular Disorder & Hypertension, Cancer), By Region And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

北美家庭醫療保健市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，2030年北美家庭醫療保健市場規模預計將達到2,850.5億美元，2024年至2030年複合年成長率為7.7%。

推動成長的主要因素包括人口老化、可用於醫療保健支出的高水平可支配收入以及越來越多的目標疾病。慢性病占主導地位，診斷成本上升預計將推動成長。

個人化醫療援助是控制治療成本的一種經濟有效的手段，也是該產業的關鍵驅動力。根據美國健康排名，到 2022 年，美國將有大約 5,800 萬 65 歲及以上的成年人居住。

預計家庭醫療保健產業將在很大程度上受到大量老齡化人口的推動，這些人口容易患上各種疾病，例如靜脈淤滯性潰瘍、糖尿病性潰瘍和壓瘡。根據世界衛生組織統計，2014年全球60歲以上人口數達8.41億，預計2050年將達20億。因此，全球老化速度不斷加快，據統計，約70%的家庭醫療患者屬於65歲及以上年齡層，預計在不久的將來推動需求。

2014年創傷護理佔全球市場收益的65%。對傷口縫合材料、創傷護理敷料和傷口清洗的巨大需求導致了過去幾年該領域的主導地位，預計這種趨勢在預測期內將持續下去。由於傷口感染是醫護人員和患者的關鍵安全問題，預計市場將受到感染率下降的推動，從而推動需求。創傷護理產品可改善患有糖尿病潰瘍、壓瘡和靜脈瘀血性潰瘍等各種疾病的患者的整體健康狀況，從而在行業中產生了對這些產品的強烈需求。

由於個人安全和衛生意識的提高，老年患者數量的增加預計將進一步增加北美對家庭醫療保健服務的需求。百特提供廣泛的解決方案，為醫療保健專業人員提供個人化照護。我們為醫療保健專業人員提供產品，包括醫院護理、基層醫療、腎臟護理、外科護理和營養護理。

2023年，服務業的市場佔有率最大，達84.1%。此細分市場進一步分為熟練家庭護理和非熟練家庭護理。家庭醫療保健服務提供多種服務，包括營養支持、護理、臨終關懷和安寧療護以及醫生的基層醫療。熟練的醫療保健人員提供的準確診斷和治療有助於該細分市場的成長。同時，設備產業預計在預測期內複合年成長率為8.6%。此部分分為治療、診斷和行動輔助部分。

由於其先進的醫療保健基礎設施，美國家庭醫療保健市場在 2023 年以 90.0% 的佔有率主導北美市場。推動成長的主要因素包括人口老化、不斷發展的醫療基礎設施和高購買力。此外，旨在透過促進家庭護理服務來控制治療成本的政府措施預計將支持成長。根據人口研究所 (PRB) 的數據，北美 65 歲及以上人口目前約為 5,000 萬，預計到 2050 年將達到 8,900 萬。

北美家庭醫療保健市場報告亮點

  • 2023年，服務業將擁有最大的市場佔有率，達到84.1%。此細分市場進一步分為熟練家庭護理和非熟練家庭護理。
  • 預計設備產業在預測期內的複合年成長率將達到 8.6%，是最快的。此部分分為治療、診斷和行動輔助部分。
  • 2023年，糖尿病/腎臟疾病領域將佔據最大的市場佔有率。據美國糖尿病協會稱，2021 年有 3,840 萬美國被診斷出患有糖尿病。
  • 預計行動障礙市場在預測期內將以最快的複合年成長率成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章北美家庭醫療保健市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 北美家庭醫療保健市場分析工具
    • 波特的分析
    • PESTEL分析

第4章北美家庭醫療保健市場：成分估計與趨勢分析

  • 細分儀表板
  • 北美家庭醫療保健市場：2023 年和 2030 年成分變化分析
  • 裝置
  • 服務

第5章 北美家庭醫療保健市場：指標估算與趨勢分析

  • 細分儀表板
  • 北美家庭醫療保健市場：2023 年和 2030 年適應症變化分析
  • 心血管疾病與高血壓
  • 糖尿病和腎臟疾病
  • 神經和精神疾病
  • 呼吸系統疾病與慢性阻塞性肺病
  • 母體疾病
  • 運動障礙
  • 癌症
  • 創傷護理
  • 其他

第6章北美家庭醫療保健市場：區域估計和趨勢分析

  • 2023 年及 2030 年北美家庭醫療保健市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • B. Braun SE
    • Abbott
    • Sunrise Medical
    • 3M
    • Baxter
    • Medtronic
    • Cardinal Health
    • F. Hoffmann-La Roche Ltd
    • Amedisys
    • ARKRAY, Inc.
    • BD
    • OMRON Healthcare, Inc.
    • GE Healthcare
    • Medline Industries, Inc
    • Koninklijke Philips NV
    • Johnson &Johnson Services, Inc.
    • Acelity（3M）
    • Teleflex Incorporated.
    • Fresenius Kabi AG.
    • Bayer AG
    • GF Health Products, Inc.
    • Knight Health Holdings, LLC
    • NHC, National Healthcare Corporation
    • Gentiva
    • Medco Home Healthcare, Inc.
    • Brookdale Senior Living Inc.
    • Sunrise Senior Living
    • Genesis HealthCare
    • EXTENDICARE.
    • Diversicare.
    • Home Instead, Inc.
    • Senior Services of America
    • Atria Senior Living, Inc
簡介目錄
Product Code: 978-1-68038-607-3

North America Home Healthcare Market Growth & Trends:

The North America home healthcare market size is expected to reach USD 285.05 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising aging human population, high disposable income for healthcare expenditure, and increasing rate of target diseases are some of the key factors driving growth. Predominance of chronic diseases, and increasing diagnosis expenditure is anticipated to boost growth.

Personalized medical assistance is a cost effective measure to control treatment expenditure and acts as a major driver for the industry. According to America's Health rankings, nearly 58 million adults aged 65 and older lived in the U.S. in 2022.

The home healthcare industry is anticipated to be majorly driven by the huge aging population volume which is highly prone to various diseases such as venous stasis ulcers, diabetic ulcers, and pressure ulcers. According to WHO, the global volume of population falls under the age group of 60 years and above has reached 841 million in 2014 and is expected to reach 2 billion by 2050. Therefore, rising global aging-population along with the statistics that approximately 70% of home healthcare patients belong to 65 years and above age group, is anticipated to fuel demand in the near future.

Wound care accounted for 65% of the global market revenue in 2014. Substantial demand for wound closures, wound care dressings, and wound cleanser has resulted in the dominance of the segment over the past few years and this trend is expected to continue over the forecast period. Wound infection is a key safety concern for medical professionals and patients, thus the market is anticipated to fuel the demand as it compelled to reduce the infection rates. Wound care products improve the overall health of patients affected from various disorders such as, diabetic ulcers, pressure ulcers and venous stasis ulcers, therefore creating strong need for these products in the industry.

Rising number of geriatric patients with growing awareness about personal safety and hygiene is further expected to intensify home healthcare service demand in North America. Baxter offers broad solutions to empower healthcare professionals to offer personalized care. It offers products for healthcare professionals for hospital care, primary care, kidney care, surgical care, nutritional care and others.

The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare. Different services such as nutritional support, nursing care, hospice & palliative, physician primary care, and others are offered by home healthcare services. The accurate diagnosis and medical treatment offered by skilled healthcare is attributing the segment growth. On the other hand, the equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.

The U.S. home healthcare market dominated the North America market with a share of 90.0% in 2023 due to advanced healthcare infrastructure. Large base of aging population, growing healthcare infrastructure and high purchasing power are some of the key factors driving growth. Moreover, favorable government initiatives aimed at controlling treatment expenditure by promoting home care services are anticipated to fuel growth. According to the PRB (Population Reference Bureau), at present, approximately 50 million citizens of North America are over 65 years and the number is projected to reach 89 million by 2050.

North America Home Healthcare Market Report Highlights:

  • The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare.
  • The equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.
  • The diabetes & kidney disorders segment accounted for the largest market share in 2023. According to American Diabetes Association, 38.4 million Americans were diagnosed with diabetes in 2021.
  • The mobility disorders segment is projected to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Home Healthcare Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. North America Home Healthcare Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. North America Home Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Home Healthcare Market: Component Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Therapeutic
      • 4.3.2.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.1. Home Respiratory Equipment
          • 4.3.2.1.1.1. Home Respiratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.2. Insulin Delivery Market
          • 4.3.2.1.2.1. Insulin Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.3. Home IV Pumps
          • 4.3.2.1.3.1. Home IV Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.4. Home Dialysis Equipment
          • 4.3.2.1.4.1. Home Dialysis Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.5. Other Therapeutic Equipment
          • 4.3.2.1.5.1. Other Therapeutic Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Diagnostic
      • 4.3.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.1. Diabetic Care Unit
          • 4.3.3.1.1.1. Diabetic Care Unit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.2. BP Monitors
          • 4.3.3.1.2.1. BP Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.3. Multi Para Diagnostic Monitors
          • 4.3.3.1.3.1. Multi Para Diagnostic Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.4. Home Pregnancy and Fertility Kits
          • 4.3.3.1.4.1. Home Pregnancy and Fertility Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.5. Apnea and Sleep Monitors
          • 4.3.3.1.5.1. Apnea and Sleep Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.6. Holter Monitors
          • 4.3.3.1.6.1. Holter Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.7. Heart Rate Meters (include pacemakers)
          • 4.3.3.1.7.1. Heart Rate Meters (include pacemakers) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.8. Others
          • 4.3.3.1.8.1. Other Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Mobility Assist
      • 4.3.4.1. Mobility Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.1. Wheel Chair
          • 4.3.4.1.1.1. Wheel Chair Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.2. Home Medical Furniture
          • 4.3.4.1.2.1. Home Medical Furniture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.3. Walking Assist Devices
          • 4.3.4.1.3.1. Walking Assist Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Skilled Home Healthcare
      • 4.4.2.1. Skilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.1. Physician Primary Care
          • 4.4.2.1.1.1. Physician Primary Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.2. Nursing Care
          • 4.4.2.1.2.1. Nursing Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.3. Physical/Occupational/Speech Therapy
          • 4.4.2.1.3.1. Physical/Occupational/Speech Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.4. Nutritional Support
          • 4.4.2.1.4.1. Nutritional Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.5. Hospice & Palliative
          • 4.4.2.1.5.1. Hospice & Palliative Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.6. Other Skilled Nursing Services
          • 4.4.2.1.6.1. Other Skilled Nursing Se Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Unskilled Home Healthcare
      • 4.4.3.1. Unskilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Home Healthcare Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Home Healthcare Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular Disorder & Hypertension
    • 5.3.1. Cardiovascular Disorder & Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Diabetes & Kidney Disorders
    • 5.4.1. Equipment Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Neurological & Mental Disorders
    • 5.5.1. Neurological & Mental Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Respiratory Diseases & COPD
    • 5.6.1. Respiratory Diseases & COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Maternal Disorders
    • 5.7.1. Maternal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Mobility Disorders
    • 5.8.1. Mobility Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Cancer
    • 5.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Wound Care
    • 5.10.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Other Indications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Home Healthcare Market: Regional Estimates & Trend Analysis

  • 6.1. North America Home Healthcare Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Abbott
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Sunrise Medical
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. 3M
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Baxter
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Medtronic
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Cardinal Health
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. F. Hoffmann-La Roche Ltd
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Amedisys
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. ARKRAY, Inc.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. BD
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. OMRON Healthcare, Inc.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. GE Healthcare
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives
    • 7.4.14. Medline Industries, Inc
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/ Strategic Initiatives
    • 7.4.15. Koninklijke Philips N.V.
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/ Strategic Initiatives
    • 7.4.16. Johnson & Johnson Services, Inc.
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/ Strategic Initiatives
    • 7.4.17. Acelity (3M)
      • 7.4.17.1. Participant's Overview
      • 7.4.17.2. Financial Performance
      • 7.4.17.3. Product Benchmarking
      • 7.4.17.4. Recent Developments/ Strategic Initiatives
    • 7.4.18. Teleflex Incorporated.
      • 7.4.18.1. Participant's Overview
      • 7.4.18.2. Financial Performance
      • 7.4.18.3. Product Benchmarking
      • 7.4.18.4. Recent Developments/ Strategic Initiatives
    • 7.4.19. Fresenius Kabi AG.
      • 7.4.19.1. Participant's Overview
      • 7.4.19.2. Financial Performance
      • 7.4.19.3. Product Benchmarking
      • 7.4.19.4. Recent Developments/ Strategic Initiatives
    • 7.4.20. Bayer AG
      • 7.4.20.1. Participant's Overview
      • 7.4.20.2. Financial Performance
      • 7.4.20.3. Product Benchmarking
      • 7.4.20.4. Recent Developments/ Strategic Initiatives
    • 7.4.21. GF Health Products, Inc.
      • 7.4.21.1. Participant's Overview
      • 7.4.21.2. Financial Performance
      • 7.4.21.3. Product Benchmarking
      • 7.4.21.4. Recent Developments/ Strategic Initiatives
    • 7.4.22. Knight Health Holdings, LLC
      • 7.4.22.1. Participant's Overview
      • 7.4.22.2. Financial Performance
      • 7.4.22.3. Product Benchmarking
      • 7.4.22.4. Recent Developments/ Strategic Initiatives
    • 7.4.23. NHC, National Healthcare Corporation
      • 7.4.23.1. Participant's Overview
      • 7.4.23.2. Financial Performance
      • 7.4.23.3. Product Benchmarking
      • 7.4.23.4. Recent Developments/ Strategic Initiatives
    • 7.4.24. Gentiva
      • 7.4.24.1. Participant's Overview
      • 7.4.24.2. Financial Performance
      • 7.4.24.3. Product Benchmarking
      • 7.4.24.4. Recent Developments/ Strategic Initiatives
    • 7.4.25. Medco Home Healthcare, Inc.
      • 7.4.25.1. Participant's Overview
      • 7.4.25.2. Financial Performance
      • 7.4.25.3. Product Benchmarking
      • 7.4.25.4. Recent Developments/ Strategic Initiatives
    • 7.4.26. Brookdale Senior Living Inc.
      • 7.4.26.1. Participant's Overview
      • 7.4.26.2. Financial Performance
      • 7.4.26.3. Product Benchmarking
      • 7.4.26.4. Recent Developments/ Strategic Initiatives
    • 7.4.27. Sunrise Senior Living
      • 7.4.27.1. Participant's Overview
      • 7.4.27.2. Financial Performance
      • 7.4.27.3. Product Benchmarking
      • 7.4.27.4. Recent Developments/ Strategic Initiatives
    • 7.4.28. Genesis HealthCare
      • 7.4.28.1. Participant's Overview
      • 7.4.28.2. Financial Performance
      • 7.4.28.3. Product Benchmarking
      • 7.4.28.4. Recent Developments/ Strategic Initiatives
    • 7.4.29. EXTENDICARE.
      • 7.4.29.1. Participant's Overview
      • 7.4.29.2. Financial Performance
      • 7.4.29.3. Product Benchmarking
      • 7.4.29.4. Recent Developments/ Strategic Initiatives
    • 7.4.30. Diversicare.
      • 7.4.30.1. Participant's Overview
      • 7.4.30.2. Financial Performance
      • 7.4.30.3. Product Benchmarking
      • 7.4.30.4. Recent Developments/ Strategic Initiatives
    • 7.4.31. Home Instead, Inc.
      • 7.4.31.1. Participant's Overview
      • 7.4.31.2. Financial Performance
      • 7.4.31.3. Product Benchmarking
      • 7.4.31.4. Recent Developments/ Strategic Initiatives
    • 7.4.32. Senior Services of America
      • 7.4.32.1. Participant's Overview
      • 7.4.32.2. Financial Performance
      • 7.4.32.3. Product Benchmarking
      • 7.4.32.4. Recent Developments/ Strategic Initiatives
    • 7.4.33. Atria Senior Living, Inc
      • 7.4.33.1. Participant's Overview
      • 7.4.33.2. Financial Performance
      • 7.4.33.3. Product Benchmarking
      • 7.4.33.4. Recent Developments/ Strategic Initiatives